XML 82 R70.htm IDEA: XBRL DOCUMENT v3.25.2
Share-based Payments (Summary of Share Unit Activity) (Details)
6 Months Ended
Jun. 30, 2025
$ / shares
shares
Performance Share Units (Performance Conditions) | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 450,175
Granted, Shares | shares 149,751
Vested and settled, Shares | shares (132,018)
Forfeited, Shares | shares (2,990)
Outstanding ending balance, Shares | shares 464,918
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 64.73
Granted, Weighted average grant date fair value (usd per share) | $ / shares 95.53
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 58.74
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 67.48
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 76.33
Performance Share Units (Market Conditions) | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 268,954
Granted, Shares | shares 149,521
Vested and settled, Shares | shares 0
Forfeited, Shares | shares (1,705)
Outstanding ending balance, Shares | shares 416,770
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 105.53
Granted, Weighted average grant date fair value (usd per share) | $ / shares 139.83
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 0
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 120.49
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 117.77
Restricted Share Units | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 607,805
Granted, Shares | shares 461,047
Vested and settled, Shares | shares (282,660)
Forfeited, Shares | shares (12,771)
Outstanding ending balance, Shares | shares 773,421
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 66.00
Granted, Weighted average grant date fair value (usd per share) | $ / shares 97.52
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 63.34
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 70.91
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 85.68
Deferred Share Units | Liability-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 73,490
Granted, Shares | shares 415
Vested and settled, Shares | shares (2,245)
Forfeited, Shares | shares 0
Outstanding ending balance, Shares | shares 71,660
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 40.29
Granted, Weighted average grant date fair value (usd per share) | $ / shares 101.31
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 67.40
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 0
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 39.79